08:40 | FRO: Development of a next-generation sequencing platform for retinal dystrophies, with LCA and RP as proof of concept. | COPPIETERS F | ||
08:50 | Colour Vision in Stargardt Disease | VANDENBROUCKE T, BUYL R, DE ZAEYTIJD J, UVIJLS A, DE BAERE E, LEROY BP | ||
09:00 | New classification of uveitis | KESTELYN P | ||
09:30 | Case reports | |||
10:30 | Break | |||
11:00 | Retinal drug toxicity: state of the art in monitoring - part 1 | SPILEERS W | ||
11:20 | Retinal drug toxicity: state of the art in monitoring - part 2 | DE ZAEYTIJD J | ||
11:40 | Retinal drug toxicity: state of the art in monitoring - part 3 | LEROY BP | ||
12:00 | FRO: Analysis of the utility of QuantiFERON-TB Gold in tube and measurement of IFNγ release by peripheral mononuclear cells in response to different mycobacterium antigen in the work-up of patients with uveitis | MAKHOUL D | ||
12:10 | FRO: Study of the role of P2Y receptors in the development of experimental autoimmune uveitis | JUDICE DE MENEZES RELVAS L, WILLERMAIN F | ||
12:20 | Les uvéites chez l’enfant congolais | KAIMBO WA KAIMBO D | ||
12:30 | Break |